Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 H&D Wireless Sweden Holding B HDWB Apr 25, 2025 0.00 +11.11   
 H&M B HMB Apr 25, 2025 141.40 -0.25   
 HAKI Safety A HAKIA Apr 25, 2025 25.40 -0.78   
 HAKI Safety B HAKIB Apr 25, 2025 23.85 -1.95   
 Hamlet BioPharma AB (publ) HAMLETB Apr 25, 2025 4.43 +2.31   
 Hansa Biopharma HNSA Apr 25, 2025 28.36 +19.76   
 Hanza AB HANZA Apr 25, 2025 72.00 +0.14   
 Havsfrun Investment HAVS Apr 25, 2025 15.20 -6.11   
 Havsfrun Investment B HAVB Apr 25, 2025 15.20 -6.11   
 Haypp Group HAYPP Apr 25, 2025 99.60 -0.40   
 Headsent VIMAB Apr 25, 2025 8.62 +4.87   
 Heba B HEBAB Apr 25, 2025 28.80 +1.12   
 Hedera Group HEGR Apr 25, 2025 3.20 +7.38   
 Heimstaden Pref HEIMPREF Apr 25, 2025 13.12 -0.15   
 Heliospectra HELIO Apr 25, 2025 0.29 -7.74   
 Hemnet Group HEM Apr 25, 2025 335.60 -12.28   
 Hemply Balance HMPLY Apr 25, 2025 0.03 0.00   
 Hernö Gin B HERNOB Apr 25, 2025 3.93 -0.51   
 Hexagon B HEXAB Apr 25, 2025 93.36 +2.50   
 Hexagon Purus HPURO Apr 25, 2025 2.00 -7.41   
 Hexatronic Group HTRO Apr 25, 2025 27.88 +2.69   
 Hexicon HEXI Apr 25, 2025 0.23 -1.28   
 Hexpol B HPOLB Apr 25, 2025 86.35 +1.77   
 Hifab B HIFAB Apr 25, 2025 3.66 +0.55   
 High Coast Distillery B HIGHCOB Apr 25, 2025 47.00 +3.98   
 Hilbert HILBB Apr 25, 2025 4.19 -0.95   
 HMS Networks HMS Apr 25, 2025 431.00 +0.05   
 Hoegh Autoliners ASA HAUTOO Apr 25, 2025 79.88 +3.07   
 Hoi Publishing AB HOIB Apr 25, 2025 0.17 -5.08   
 Hoist Finance HOFI Apr 25, 2025 81.65 +2.83   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.